emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Recipharm Italia / Mitim

No EMAT : 77609
Announced Date : 23/02/2016
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Recipharm Italia

Target : Mitim
Country : Italy
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Mitim is a pharmaceutical contract manufacturing company located in Brescia, Northern Italy. > Product portfolio includes beta lactams in dry sterile powder for injectable solutions, tablets and...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : ***
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
01/05/2010 Private Group led by Galia Gestion Gabilly (now Lyamtech) France * 77384
21/05/2013 Össur hf TeamOlmed Syd Sweden *** 77362

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report